Robert Polke
Career history of Robert Polke
Former positions of Robert Polke
Companies | Position | Start | End |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
ENDO INTERNATIONAL PLC | Chief Operating Officer | 31/10/2020 | - |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | - | - |
Circa Pharmaceuticals, Inc. | Chief Operating Officer | - | - |
BML Pharmaceuticals, Inc.
BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Chief Operating Officer | - | - |
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Chief Operating Officer | - | - |
PAR PHARMACEUTICAL COMPANIES, INC. | Chief Tech/Sci/R&D Officer | 15/06/2010 | 27/04/2014 |
Corporate Officer/Principal | - | - |
Training of Robert Polke
St. John's University | Masters Business Admin |
Statistics
International
United States | 8 |
Ireland | 2 |
Operational
Chief Operating Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 6 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
BML Pharmaceuticals, Inc.
BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Commercial Services |
Circa Pharmaceuticals, Inc. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Robert Polke
- Experience